Delivery Order SPE2DE24DA010-SPE2D626F167D
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $60,563.90 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, with an ultimate completion date of September 19, 2025. The contract, designated as GALLANT (Contract Number 4569469210), was awarded without a set-aside designation, indicating full and open competition. The place of performance is located in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order valued at $21,425.00 under contract number 4569403311 (GALLANT) by the Defense Logistics Agency's Medical Supply Chain organization. The fixed-price delivery order with economic price adjustment was awarded on September 10, 2025, with an ultimate completion date of September 15, 2025, with performance to take place in Santa Clara, California. This award represents a competitive procurement with...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $39,142.80 by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025. The contract, designated GALLANT (4569455082), carries no set-aside designation, indicating full and open competition. Performance will be completed in Santa Clara, California, with an ultimate completion date of September 17, 2025. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $37,164.80 by the Medical Supply Chain division of the Department of Defense on June 18, 2025, with a completion date of June 24, 2025. The award is designated as a fixed-price contract with economic price adjustment and was issued without a set-aside, indicating full and open competition. Performance will be executed at Abbott's facility in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $25,715.85 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as GALLANT (4569142750), will be performed in Santa Clara, California, and represents a non-set-aside award made through full and open competition. Abbott Vascular specializes in advanced cardiovascular medical...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order valued at $22,780.00 by the Medical Supply Chain division of the Department of Defense. This fixed-price delivery order with economic price adjustment was issued on September 16, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Santa Clara, California. The award was made under full and open competition with no set-aside designation. The delivery order...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F167DDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $21,147 fixed-price delivery order (Contract 4570006266, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. The delivery order, issued without any small business set-aside, is for performance at Abbott's Santa Clara, California location. This award represents a task order under Abbott's established relationship with the Defense Logistics Agency, which maintains a major $117.1 million indefinite delivery contract with Abbott Vascular for comprehensive cardiovascular procedural packages, devices, instrumentation, and accessories that support complex medical procedures across the Department of Defense and military healthcare systems. Abbott Vascular has established itself as a critical federal supplier of advanced cardiovascular medical technologies, including stents, pacemakers, heart valves, implantable cardiac monitors, left ventricular assist devices, and transcatheter valve repair systems such as MitraClip. The company competes successfully through full and open competition mechanisms and maintains an extensive portfolio of indefinite delivery contracts across multiple Veterans Integrated Service Networks and federal healthcare agencies. This delivery order reflects the ongoing demand for Abbott's cardiovascular technologies to support federal healthcare procurement objectives and the company's strategic importance to the government's medical supply infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.1k | 11/14/25 |